Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Sanofi Consumer Healthcare India Days Inventory?
Sanofi Consumer Healthcare IndiaNSE:SANOFICONR -0.84%21 Days Inventory is 100.50 as of Mar. 2026, which is 8% below its 10-year median of 109.68. GuruFocus rates NSE:SANOFICONR with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 921 Drug Manufacturers companies, Sanofi Consumer Healthcare India ranks better than 83.82% on this metric.
The historical rank and industry rank for Sanofi Consumer Healthcare India's Days Inventory or its related term are showing as below:
NSE:SANOFICONR'
s Days Inventory Range Over the Past 10 Years
Min: 67.05 Med: 109.68 Max: 181.75
Current: 88.88
During the past 3 years, Sanofi Consumer Healthcare India's highest Days Inventory was 181.75. The lowest was 67.05. And the median was 109.68.
NSE:SANOFICONR's Days Inventory is ranked better than 83.82% of 921
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs NSE:SANOFICONR: 88.88
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sanofi Consumer Healthcare India's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.91.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sanofi Consumer Healthcare India's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.27.
Sanofi Consumer Healthcare India (NSE:SANOFICONR) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sanofi Consumer Healthcare India's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sanofi Consumer Healthcare India's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sanofi Consumer Healthcare India Days Inventory Related Terms
Sanofi Consumer Healthcare India Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanofi Consumer Healthcare India Days Inventory Chart
NSE:SANOFICONR vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Sanofi Consumer Healthcare India's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanofi Consumer Healthcare India Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sanofi Consumer Healthcare India's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sanofi Consumer Healthcare India's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a Days Inventory of 100.50 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sanofi Consumer Healthcare India and its competitors. This is near median its historical median of 109.68. Over the past decade, Sanofi Consumer Healthcare India's Days Inventory has ranged from 67.05 to 181.75. According to the industry distribution chart, Sanofi Consumer Healthcare India ranks #149 out of 921 companies in the Drug Manufacturers industry, placing it in the top 16.2%.
Is Sanofi Consumer Healthcare India's Days Inventory too high?
Sanofi Consumer Healthcare India's current Days Inventory of 100.50 is near median its 10-year median of 109.68. Over the past 10 years, this metric has ranged from a low of 67.05 to a high of 181.75. The Drug Manufacturers industry median Days Inventory is 164.48. Sanofi Consumer Healthcare India's value of 100.50 is 38.9% below this industry median. Based on the distribution chart, Sanofi Consumer Healthcare India ranks #149 out of 921 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sanofi Consumer Healthcare India has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Sanofi Consumer Healthcare India's Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Sanofi Consumer Healthcare India ranks #149 out of 921 companies for Days Inventory. This places Sanofi Consumer Healthcare India in the top 16% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.48. Sanofi Consumer Healthcare India's value of 100.50 is 38.9% below this benchmark. Historically, Sanofi Consumer Healthcare India's own Days Inventory has ranged from 67.05 to 181.75 over the past decade. While the company's 10-year median is 109.68 vs. the industry median of 164.48, Sanofi Consumer Healthcare India has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanofi Consumer Healthcare India's current Days Inventory of 100.50 is 38.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sanofi Consumer Healthcare India and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanofi Consumer Healthcare India's current Days Inventory is 100.50, which is near median its own 10-year median of 109.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi Consumer Healthcare India stock overvalued right now?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a current Days Inventory of 100.50. The current Days Inventory is 100.50, which is near median its 10-year median of 109.68 and 38.9% below the Drug Manufacturers industry median of 164.48. Sanofi Consumer Healthcare India's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sanofi Consumer Healthcare India (NSE:SANOFICONR), the current Days Inventory is 100.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sanofi Consumer Healthcare India Business Description
Sanofi Consumer Healthcare India Ltd is mainly engaged in the business of manufacturing and trading of drugs and pharmaceutical products. The Company also has various independent contract/third-party manufacturers based across the country and provides business support services to its group entity in India. Its products include Allergy Relief (Allegra), Pain Care (Combiflam), and Physical Wellness (DePURA). The Company sells its products in India through independent distributors and outside India. Its operations are limited to one segment, namely Pharmaceutical Business. The Company operates in India, which generates the maximum revenue, and Outside India.
21GF Score
Get the complete analysis for NSE:SANOFICONR
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SANOFICONR has been successfully added to your 
